ArticleHeliyon2024
Hybrid ensemble deep learning model for advancing breast cancer detection and classification in clinical applications.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic literature review on mammography: deep learning techniques for breast cancer detection with global and Asian perspectives.BMC cancer · 2025Pooled it
- Performance evaluation of deep learning based YOLOv5 and YOLOv8 models for real time breast cancer detection in mammographic images.Discover oncology · 2026Article
- FT-MDNNMDs: early detection of breast cancer using fine-tuned multi-deep neural networks with TCGA and clinical image datasets.Scientific reports · 2026Article
- Different BI-RADS breast cancer diagnosis using MobileNetV1 and vision transformer based on explainable artificial intelligence (XAI).Scientific reports · 2026Article
- Artificial intelligence-driven multimodal fusion for precision diagnosis and personalized management of breast cancer.Oncology reviews · 2026Review
- FGOOPNet: A Fuzzy Deep Learning Approach for Mammographic Breast Cancer ClassificationCurrent medical imaging · 2026Article
- Explainable Deep Learning for Breast Lesion Classification in Digital and Contrast-Enhanced Mammography.Diagnostics (Basel, Switzerland) · 2025Article
- A robust stacked neural network approach for early and accurate breast cancer diagnosis.Frontiers in medicine · 2025Article
- Divulging Patterns: An Analytical Review for Machine Learning Methodologies for Breast Cancer Detection.Journal of Cancer · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Being the most common type of cancer worldwide, and affecting over 2.3 million women, breast cancer poses a significant health threat. Although survival rates have improved around the world due to advances in screening, diagnosis, and treatment, early detection remains crucial for effective management. This study seeks to introduce a novel hybrid model that makes use of image-preprocessing techniques and deep-learning algorithms on mammograms to enhance the detection and classification accuracy of breast cancer lesions. The model was tested on a dataset comprising 20,000 mammograms. First, image-processing techniques, such as Contrast-Limited Adaptive Histogram Equalization, Gaussian Blur, and sharpening methods were used to optimize the images for enhanced feature extraction. In addition, the Ensemble Deep Random Vector-Functional Link Neural Network algorithm, YOLOv5, and MedSAM segmentation models were utilized for robust deep learning-based extraction, classification, and visualization of lesions. Finally, the model was clinically validated on 800 patients. The study found a notable enhancement in both accuracy and processing time for benign and malignant diagnoses using the hybrid model. The model achieves an impressive accuracy of 99.7 % and demonstrates a remarkable processing time of 0.75 s. In clinical applications, the hybrid model exhibits high proficiency, reporting 97.2 % accuracy for benign cases and 98.6 % for malignant scenarios. These results highlight the effectiveness of the hybrid model in improving diagnostic accuracy, offering a promising tool for early breast cancer detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.